256 related articles for article (PubMed ID: 36039926)
1. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
[TBL] [Abstract][Full Text] [Related]
3. New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review.
Tzeng M; Basourakos SP; Lewicki PJ; Hu JC; Lee RK
Eur Urol Focus; 2022 Mar; 8(2):522-531. PubMed ID: 33663982
[TBL] [Abstract][Full Text] [Related]
4. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection.
Tutrone RF; Schiff W
Can J Urol; 2020 Jun; 27(3):10213-10219. PubMed ID: 32544043
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia.
Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Amorosi SL; Shore ND
J Health Econ Outcomes Res; 2021 May; 8(1):42-50. PubMed ID: 33987450
[No Abstract] [Full Text] [Related]
6. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
[TBL] [Abstract][Full Text] [Related]
8. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
[TBL] [Abstract][Full Text] [Related]
10. Rezūm water vapor thermal therapy in patients with benign prostatic hyperplasia: Initial real-world data from Japan.
Obinata D; Mochida J; Uehara R; Osawa M; Hashimoto S; Nakahara K; Yoshizawa T; Yamaguchi K; Takahashi S
Medicine (Baltimore); 2023 Nov; 102(46):e36055. PubMed ID: 37986385
[TBL] [Abstract][Full Text] [Related]
11. Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes.
Garden EB; Shukla D; Ravivarapu KT; Kaplan SA; Reddy AK; Small AC; Palese MA
World J Urol; 2021 Aug; 39(8):3041-3048. PubMed ID: 33392646
[TBL] [Abstract][Full Text] [Related]
12. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia.
McVary KT; El-Arabi A; Roehrborn C
Sex Med; 2021 Dec; 9(6):100454. PubMed ID: 34731779
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.
Sahakyan Y; Erman A; Bhojani N; Chughtai B; Zorn KC; Sander B; Elterman DS
Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):113-118. PubMed ID: 35689083
[TBL] [Abstract][Full Text] [Related]
14. A novel metric for treatment durability in clinical trials of minimally invasive treatments for benign prostatic hyperplasia.
Miller LE; Te AE; Bhattacharyya SK; Lilienfeld S; Dornbier RA; McVary KT
Expert Rev Med Devices; 2020 Apr; 17(4):365-369. PubMed ID: 32189535
[No Abstract] [Full Text] [Related]
15. Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective.
Sahakyan Y; Erman A; Bhojani N; Chughtai B; Zorn KC; Sander B; Elterman DS
Can Urol Assoc J; 2023 Apr; 17(4):103-110. PubMed ID: 36486181
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Fu S; Bhattacharyya SK; El-Arabi AM; Cutone BJ; McVary KT
PLoS One; 2022; 17(4):e0266824. PubMed ID: 35427376
[TBL] [Abstract][Full Text] [Related]
17. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
Tanneru K; Jazayeri SB; Alam MU; Kumar J; Bazargani S; Kuntz G; Palayapalayam Ganapathi H; Bandyk M; Marino R; Koochekpour S; Gautam S; Balaji KC; Costa J
J Endourol; 2021 Apr; 35(4):409-416. PubMed ID: 32962442
[No Abstract] [Full Text] [Related]
18. Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison.
Tallman CT; Zantek PF; Hernandez N; Morton RA; Qi D; Gonzalez RR
World J Urol; 2021 Sep; 39(9):3207-3215. PubMed ID: 33515055
[TBL] [Abstract][Full Text] [Related]
19. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
Eure G; Rukstalis D; Roehrborn C
J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
[No Abstract] [Full Text] [Related]
20. Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and Aquablation.
Bilhim T; Betschart P; Lyatoshinsky P; Müllhaupt G; Abt D
Cardiovasc Intervent Radiol; 2022 Apr; 45(4):415-424. PubMed ID: 35043243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
